Related references
Note: Only part of the references are listed.Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
Stefan Zeuzem et al.
GASTROENTEROLOGY (2014)
Validation of the Fatigue Severity Scale in chronic hepatitis C
Kathleen Rosa et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2014)
Once-Daily Simeprevir (TMC435) With Pegylated Interferon and Ribavirin in Treatment-Naive Genotype 1 Hepatitis C: The Randomized PILLAR Study
Michael W. Fried et al.
HEPATOLOGY (2013)
INTERVIEWS WITH PATIENTS WITH CHRONIC HEPATITIS C (CHC) VIRUS INFECTION DOCUMENT UNMET NEEDS, CONTENT VALIDITY, AND COMPREHENSION OF PROS FOR CLINICAL TRIALS
S. Blackburn et al.
VALUE IN HEALTH (2013)
Hepatitis C therapy update
Lisa C. Casey et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Review of patient-reported outcome measures in chronic hepatitis C
Leah Kleinman et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2012)
Fatigue before, during and after antiviral therapy of chronic hepatitis C: Results from the Virahep-C study
Souvik Sarkar et al.
JOURNAL OF HEPATOLOGY (2012)
A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C
I. M. Jacobson et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow
Tarik Asselah et al.
LIVER INTERNATIONAL (2012)
Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia
Asli Gencay-Can et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mapping onto Eq-5 D for patients in poor health
Matthijs M. Versteegh et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
Fatigue Rating Scales Critique and Recommendations by the Movement Disorders Society Task Force on Rating Scales for Parkinson's Disease
Joseph H. Friedman et al.
MOVEMENT DISORDERS (2010)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Future directions for investigation of fatigue in chronic hepatitis C viral infection
Kenneth Seaman et al.
CHRONIC ILLNESS (2009)
Living with Hepatitis C: Qualitative Interviews with Hepatitis C-infected Veterans
Erik J. Groessl et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection
Jillian Kallman et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C
T Hassanein et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatitis C virus infection affects the brain -: evidence from psychometric studies and magnetic resonance spectroscopy
K Weissenborn et al.
JOURNAL OF HEPATOLOGY (2004)
Peginterferon alpha-2a (40kD) [Pegasys (R)] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon (R)-A] - In patients with chronic hepatitis C
J Rasenack et al.
PHARMACOECONOMICS (2003)
Assessment of fatigue in patients with chronic hepatitis C using the fatigue impact scale
Z Hassoun et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Fatigue in patients with chronic hepatitis C
T Poynard et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Fatigue and psychological disorders in chronic hepatitis C
J McDonald et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
D Bernstein et al.
HEPATOLOGY (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
EQ-5D: a measure of health status from the EuroQol Group
R Rabin et al.
ANNALS OF MEDICINE (2001)
Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C
L Kleinman et al.
QUALITY OF LIFE RESEARCH (2000)
Share Paper
